List of Tables
    Table 1. Cancer Supportive Care Medicine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Cancer Supportive Care Medicine Market Trends
    Table 3. Cancer Supportive Care Medicine Market Drivers
    Table 4. Cancer Supportive Care Medicine Market Challenges
    Table 5. Cancer Supportive Care Medicine Market Restraints
    Table 6. Global Cancer Supportive Care Medicine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cancer Supportive Care Medicine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cancer Supportive Care Medicine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cancer Supportive Care Medicine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cancer Supportive Care Medicine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cancer Supportive Care Medicine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Cancer Supportive Care Medicine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Cancer Supportive Care Medicine Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Cancer Supportive Care Medicine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Cancer Supportive Care Medicine Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Cancer Supportive Care Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Cancer Supportive Care Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Supportive Care Medicine as of 2021)
    Table 18. Top Players of Cancer Supportive Care Medicine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Cancer Supportive Care Medicine Product Type
    Table 20. Date of International Manufacturers Enter into Cancer Supportive Care Medicine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Cancer Supportive Care Medicine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Cancer Supportive Care Medicine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Cancer Supportive Care Medicine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Cancer Supportive Care Medicine Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Cancer Supportive Care Medicine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Cancer Supportive Care Medicine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Cancer Supportive Care Medicine Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Cancer Supportive Care Medicine Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Cancer Supportive Care Medicine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Cancer Supportive Care Medicine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Cancer Supportive Care Medicine Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Cancer Supportive Care Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Cancer Supportive Care Medicine Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Cancer Supportive Care Medicine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Cancer Supportive Care Medicine Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Cancer Supportive Care Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Cancer Supportive Care Medicine Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Cancer Supportive Care Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Cancer Supportive Care Medicine Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Cancer Supportive Care Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Amgen Corporation Information
    Table 43. Amgen Description and Business Overview
    Table 44. Amgen Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Amgen Cancer Supportive Care Medicine Product
    Table 46. Amgen Recent Development
    Table 47. Helsinn Healthcare Corporation Information
    Table 48. Helsinn Healthcare Description and Business Overview
    Table 49. Helsinn Healthcare Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Helsinn Healthcare Product
    Table 51. Helsinn Healthcare Recent Development
    Table 52. Johnson &Johnson Corporation Information
    Table 53. Johnson &Johnson Description and Business Overview
    Table 54. Johnson &Johnson Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Johnson &Johnson Product
    Table 56. Johnson &Johnson Recent Development
    Table 57. Merck Corporation Information
    Table 58. Merck Description and Business Overview
    Table 59. Merck Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Merck Product
    Table 61. Merck Recent Development
    Table 62. F. Hoffmann-La Roche Corporation Information
    Table 63. F. Hoffmann-La Roche Description and Business Overview
    Table 64. F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. F. Hoffmann-La Roche Product
    Table 66. F. Hoffmann-La Roche Recent Development
    Table 67. GlaxoSmithKline Corporation Information
    Table 68. GlaxoSmithKline Description and Business Overview
    Table 69. GlaxoSmithKline Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. GlaxoSmithKline Product
    Table 71. GlaxoSmithKline Recent Development
    Table 72. Heron Therapeutics Corporation Information
    Table 73. Heron Therapeutics Description and Business Overview
    Table 74. Heron Therapeutics Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Heron Therapeutics Product
    Table 76. Heron Therapeutics Recent Development
    Table 77. Kyowa Hakko Kirin Corporation Information
    Table 78. Kyowa Hakko Kirin Description and Business Overview
    Table 79. Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Kyowa Hakko Kirin Product
    Table 81. Kyowa Hakko Kirin Recent Development
    Table 82. Novartis Corporation Information
    Table 83. Novartis Description and Business Overview
    Table 84. Novartis Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Novartis Product
    Table 86. Novartis Recent Development
    Table 87. TESARO Corporation Information
    Table 88. TESARO Description and Business Overview
    Table 89. TESARO Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. TESARO Product
    Table 91. TESARO Recent Development
    Table 92. Teva Pharmaceutical Industries Corporation Information
    Table 93. Teva Pharmaceutical Industries Description and Business Overview
    Table 94. Teva Pharmaceutical Industries Cancer Supportive Care Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Teva Pharmaceutical Industries Product
    Table 96. Teva Pharmaceutical Industries Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Cancer Supportive Care Medicine Customers List
    Table 100. Cancer Supportive Care Medicine Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Supportive Care Medicine Product Picture
    Figure 2. Global Cancer Supportive Care Medicine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cancer Supportive Care Medicine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Cancer Supportive Care Medicine Sales 2017-2028 (K MT)
    Figure 5. United States Cancer Supportive Care Medicine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Cancer Supportive Care Medicine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Cancer Supportive Care Medicine Sales 2017-2028 (K MT)
    Figure 8. United States Cancer Supportive Care Medicine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Cancer Supportive Care Medicine Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Cancer Supportive Care Medicine Report Years Considered
    Figure 11. Product Picture of Antiemetic Drugs
    Figure 12. Product Picture of Erythropoietin-Stimulating Agents
    Figure 13. Product Picture of Granulocyte-Stimulating Agents
    Figure 14. Product Picture of Analgesics
    Figure 15. Product Picture of Others
    Figure 16. Global Cancer Supportive Care Medicine Market Share by Type in 2022 & 2028
    Figure 17. Global Cancer Supportive Care Medicine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Cancer Supportive Care Medicine Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Cancer Supportive Care Medicine Sales by Type (2017-2028) & (K MT)
    Figure 20. Global Cancer Supportive Care Medicine Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Cancer Supportive Care Medicine Price by Type (2017-2028) & (USD/MT)
    Figure 22. United States Cancer Supportive Care Medicine Market Share by Type in 2022 & 2028
    Figure 23. United States Cancer Supportive Care Medicine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Cancer Supportive Care Medicine Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Cancer Supportive Care Medicine Sales by Type (2017-2028) & (K MT)
    Figure 26. United States Cancer Supportive Care Medicine Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Cancer Supportive Care Medicine Price by Type (2017-2028) & (USD/MT)
    Figure 28. Product Picture of Chemotherapy-Induced Anemia
    Figure 29. Product Picture of Bone Metastasis
    Figure 30. Product Picture of Cancer Pain
    Figure 31. Product Picture of Other
    Figure 32. Global Cancer Supportive Care Medicine Market Share by Application in 2022 & 2028
    Figure 33. Global Cancer Supportive Care Medicine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global Cancer Supportive Care Medicine Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global Cancer Supportive Care Medicine Sales by Application (2017-2028) & (K MT)
    Figure 36. Global Cancer Supportive Care Medicine Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global Cancer Supportive Care Medicine Price by Application (2017-2028) & (USD/MT)
    Figure 38. United States Cancer Supportive Care Medicine Market Share by Application in 2022 & 2028
    Figure 39. United States Cancer Supportive Care Medicine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States Cancer Supportive Care Medicine Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States Cancer Supportive Care Medicine Sales by Application (2017-2028) & (K MT)
    Figure 42. United States Cancer Supportive Care Medicine Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States Cancer Supportive Care Medicine Price by Application (2017-2028) & (USD/MT)
    Figure 44. North America Cancer Supportive Care Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 45. North America Cancer Supportive Care Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. U.S. Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Europe Cancer Supportive Care Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 49. Europe Cancer Supportive Care Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. Germany Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. France Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.K. Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Italy Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Russia Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Asia-Pacific Cancer Supportive Care Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 56. Asia-Pacific Cancer Supportive Care Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 57. China Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Japan Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. South Korea Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. India Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Australia Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Taiwan Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Philippines Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Latin America Cancer Supportive Care Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 68. Latin America Cancer Supportive Care Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Mexico Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Brazil Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Argentina Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Middle East & Africa Cancer Supportive Care Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 73. Middle East & Africa Cancer Supportive Care Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 74. Turkey Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Saudi Arabia Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. UAE Cancer Supportive Care Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Cancer Supportive Care Medicine Value Chain
    Figure 78. Cancer Supportive Care Medicine Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed